Piperazine Ring Synthesis via One-Pot Cyclization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing piperazine rings, particularly for pyrazinocarbazole compounds like Pirlindole, face challenges such as low yields, use of expensive and hazardous reagents, and safety concerns due to exothermic reactions, making them unsuitable for industrial scales.
Innovation Solution
A two-step, one-reaction vessel process involving N-acylation and intramolecular indole acetamide cyclization under biphasic alkaline conditions, with reduced phase transfer catalyst usage, to synthesize piperazine rings efficiently and safely, allowing for the production of Pirlindole enantiomers and their pharmaceutically acceptable salts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional multistep processes are used for piperazine ring formation, then the synthesis can be achieved, but the yields are low and the process is complex
Solution Approach 1:
The patent combines multiple reaction steps (N-acylation and intramolecular cyclization) into a one-pot sequential process, eliminating intermediate isolation and purification steps. This merging of operations increases overall yield by reducing material loss during transfers and simplifies the process by converting a multistep procedure into a single continuous operation.
Solution Approach 2:
The reaction sequence is segmented into distinct phases: first N-acylation occurs under specific conditions, then without isolation, the second cyclization step is initiated by adding base. This temporal segmentation allows each reaction to proceed optimally while maintaining continuous flow, improving efficiency without sacrificing yield.
2Productivity
If sodium hydride with DMSO or DMF is used for one-step piperazine ring formation, then the reaction proceeds, but exothermic decomposition occurs causing safety hazards
Solution Approach 1:
The patent replaces the hazardous sodium hydride/DMSO or DMF system with a milder, safer base such as potassium carbonate or sodium hydroxide in aqueous or alcoholic media. These alternative bases are less prone to exothermic decomposition and can be handled more safely at scale, eliminating the thermal runaway risk while maintaining acceptable reaction efficiency.
Solution Approach 2:
The reaction conditions are changed from using strong bases (sodium hydride) in aprotic solvents (DMSO/DMF) to milder bases (potassium carbonate, sodium hydroxide) in protic or aqueous solvents. This parameter change reduces the exothermicity of the reaction and eliminates the decomposition hazard, while the two-step sequential process compensates for the milder conditions to maintain productivity.
3Reliability
If the lactam ring formation process is used, then a three-step approach is achieved, but the overall process is longer and more complex
Solution Approach 1:
The patent merges the N-acylation step and the cyclization step into a single continuous operation. After N-acylation completes, base is added directly to the same reaction mixture to initiate cyclization, eliminating the time required for intermediate isolation, characterization, and re-dissolution. This reduces total process time while maintaining the reliability of each individual reaction step.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process achieves higher yields and safety compared to existing methods, with improved efficiency in producing Pirlindole enantiomers, reducing the need for hazardous reagents and avoiding exothermic decompositions, making it suitable for industrial-scale production.
Implementation Method 1
reacting compound of formula VI or VIII and an acylating compound of formula XII in a first aprotic solvent, in the presence of an alkaline agent to yield compound of formula X
Implementation Method 2
intramolecular indole acetamide cyclisation of compound of formula X or XI in a second aprotic solvent, in the presence of an alkaline agent and a phase transfer catalyst to yield compound of formula IV
Implementation Method 3
reducing the lactam ring of compound of formula IV or XIV into compound of formula V or IX, respectively, in a third aprotic solvent, in the presence of a reducing agent
Implementation Method 4
catalytic hydrogenolysis or acidic phenyl cleavage to yield Pirlindole enantiomers of formula II or III
Data Source
AI summary
The present disclosure relates to an improved process for the synthesis of piperazine ring, particularly for the preparation of heterocyclic compounds useful as intermediates in the synthesis of pyrazinocarbazoles such as the antidepressant Pirlindole. The process described is useful to prepare Pirlindole enantiomers, or a pharmaceutically accepted salt thereof.